ioclinicalnetwork.co.uk
1205140
2023
L222AA
ioclinicalnetwork.co.uk
Podobné organizace
ANDI BULL CANCER TRUST |
|
TOPIC OF CANCER |
|
OVACOME |
|
CANCER CARE TRUST |
|
NORTHERN CANCER VOICES |
Podobné organizace global
LACNETS |
|
Incyte Charitable Giving Foundation |
|
National Community Oncology Dispensing Association |
|
Academy of Oncology Nurse Navigators Inc |
|
INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION |
Více Skupinová zdravotní praxe (HMO)
Yoga Surya International, z.s.Hradec Králové |
|
Nadační fond české internyPraha |
|
Hiporehabilitace Jupiter, z.s.Řevnice |
|
Česká společnost tělovýchovného lékařství, z.s.Praha |
|
Centrum hiporehabilitace Mirákl o.p.s.Bohuslavice |
Poslední komentáře
💙 So proud to support the incredible work of the Immuno-Oncology Clinical Network! Together, we can make a difference in the lives of those battling cancer. Let's continue to improve patient care and support our healthcare heroes! 🌟 #IOClinicalNet #Immunotherapydetail |
|
👏 Amazing initiatives from Dr. Anna Olsson-Brown and the entire IOCN team! It's inspiring to see a community dedicated to empowering healthcare professionals and enhancing the treatment experience for patients. Keep up the fantastic work! 💪 #CancerCare #ImmunoOncologydetail |
Poslední diskuze
1. What strategies can the Immuno-Oncology Clinical Network implement to enhance awareness and understanding of immunotherapy among healthcare professionals and the general public?Odpovědí: 3, Naposledy před 1 den detail |
|
2. How can we effectively address and manage the immune-mediated side effects of immunotherapy to improve patient outcomes and quality of life?Odpovědí: 3, Naposledy před 1 den detail |
V okolí
4.5
L222AA
O společnosti
- E31, E20, H30 -
IOClinicalNet IOCN The ImmunoOncology Clinical Network Upcoming IOCN Events IOCN WEBINARS Supporting those receiving immunotherapy by supporting those delivering it Our Ethos Dr Anna OlssonBrown IOCN Founder and CEO Our mission is to build an ImmunoOncology IO community to improve patient care. Immunotherapy has revolutionised cancer care and is increasingly used to treat cancer in the curative and palliative setting. Despite advances in Immunooncology treatments many challenges remain including the immunemediated side effects from treatment that hinder its use. We support all healthcare professionals involved in caring for patients receiving immunotherapy to help address these challenges.
Skupinová zdravotní praxe (HMO) Nemocnice a zařízení primární zdravotní péče Výzkum rakoviny